Together, these results suggest that N- and C-terminal ALS-associated ANXA11 mutations promote phase transitions from liquid-liquid droplets to gel-like states, and impair reversal of gel-like states once formed. Here, ANXA11 is linked to amyotrophic lateral sclerosis.